Transformation of the Clinical Trial Enterprise: Lessons Learned from the COVID-19 Pandemic
Link
Description
Summarizes findings from a literature review and expert interviews regarding the impacts of the COVID-19 pandemic on clinical trials. Explores ways that clinical trials that continued during the pandemic mitigated disruptions and lessons learned. Includes discussions regarding how decentralized clinical trials and digital health technologies reduce barriers for rural and underserved populations to enroll and participate in clinical trials.
Date
07/2024
Type
Document
Organizations
Co-Bio Consulting, HHS Office of the Assistant Secretary for Planning and Evaluation
Tagged as
Access · Emergency preparedness and response · Policy · Research methods and resources · Technology for health and human services
Related Content
Organizations (1)
- HHS Office of the Assistant Secretary for Planning and Evaluation, view details